On Tuesday, Shares of Majesco Entertainment Co. (NASDAQ:COOL), gained 8.89% to $1.47.
Majesco Entertainment Company, stated financial results for third quarter ending July 31, 2015.
David Rector, CEO stated “Majesco continues to streamline its business and this past quarter has exhibited our commitment to work towards profitability. Our operating loss fell dramitcally from $2.3 million in the year ago quarter ended July 31, 2014 to $700,000 in this past third quarter, which ended July 31, 2015. At the same time we ended the quarter with a stronger balance sheet, our cash and cash equivalents balance was $8.6 million. As we continue to reduce expenses we also continue to focus on the downloadable game market and believe the titles we are working on will be well received.”
Operating loss for the three months ended July 31, 2015 was about $0.7 million, contrast to an operating loss of $2.3 million in the comparable period in 2014, primarily reflecting expense reductions in development and marketing activities.
Majesco Entertainment Company develops, publishes, and distributes video game products primarily for casual-game consumers worldwide. The company publishes video games for various interactive entertainment hardware platforms, counting Nintendo’s DS, DSi, 3DS, Wii and WiiU, Sony’s PlayStation 3, Microsoft’s Xbox 360 and Xbox One, and the personal computers.
Shares of Rockwell Medical Inc (NASDAQ:RMTI), declined -5.23% to $11.06, during its last trading session.
Rockwell Medical, a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, declared recently the nationwide commercial availability of Triferic (ferric pyrophosphate citrate). Triferic is the only FDA approved iron product indicated to replace iron and maintain hemoglobin in hemodialysis patients in the United States.
Dr. Steven Fishbane, lead author and Chief, Division of Kidney Diseases and Hypertension, North Shore University Hospital and Long Island Jewish Medical Center, stated, “I’m very excited to be able to provide Triferic to my patients. Having iron delivered at every dialysis treatment that right away binds to transferrin and that does not induce iron overload is very similar to the slower, natural process in which iron is used in the body to maintain hemoglobin. We have seen the positive benefits Triferic has had on our patients during the clinical studies and now we are excited to have the drug available to treat patients beyond the research setting. Treating patients with a repletion therapy like IV iron has been associated with a variety of risks. Triferic, in contrast, is a true iron maintenance therapy with an exceptional safety profile and is an important new option for treating patients on chronic hemodialysis.”
Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. It offers products and services for the treatment of end-stage renal disease, chronic kidney disease, iron deficiency, secondary hyperparathyroidism, and hemodialysis.
At the end of Tuesday’s trade, Shares of La Quinta Holdings Inc (NYSE:LQ), gained 0.16% to $18.53.
La Quinta Holdings Inc., declared that it has signed a definitive purchase and sale agreement to sell 24 owned hotels. This portfolio is geographically dispersed and the vast majority of these hotels will be removed from the La Quinta system. The sale price for these assets represents an attractive EBITDA multiple and the Company anticipates to close the sale preceding to the end of 2015, subject to customary closing provisions, providing additional balance sheet flexibility at that time.
As a result of this transaction, the Company anticipates to realize a number of benefits, counting:
- Enhancement of the brand
- Improvement of several key operating metrics such as RevPAR and RevPAR Index
- Opening of additional markets for franchise development
- Reduction of near-term capital expenditure requirements
La Quinta Holdings Inc. owns, operates, and franchises select-service hotels under the La Quinta brand. It serves the upper-midscale and midscale segments. As of May 7, 2015, the company had about 870 hotels with about 86,000 rooms under the La Quinta Inn & Suites, La Quinta Inn, and LQ Hotel brands in 47 states of the United States, in addition to in Canada, Mexico, and Honduras.
Finally, Del Frisco’s Restaurant Group Inc (NASDAQ:DFRG), ended its last trade with -0.48% loss, and closed at $12.53.
Del Frisco’s Restaurant Group, declared that the Company will take part at the Stifel 2015 Consumer Conference at the New York Palace Hotel in New York City. The presentation will start at 10:55 am Eastern Time on Thursday, September 17, 2015.
Del Frisco’s Restaurant Group, Inc. develops, owns, and operates restaurants in the United States. It owns and operates restaurants under the Del Frisco’s Double Eagle Steak House, Sullivan’s Steakhouse, and Del Frisco’s Grille brand names. The company offers steaks, in addition to other menu selections, such as chops and fresh seafood.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
